Showing results (11-20 of 61) with videos related to

Sort By:
Pageof 7
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|October 14, 2010
Screening for metastasis in primary breast cancer patients having four or more axillary lymph node involvement: is it really necessary?R Uslu, M Kapkac, B Karaca, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|June 17, 2008
Docetaxel and platinum combination chemotherapy in locally advanced or metastatic head and neck cancerY Kucukzeybek, G Gorumlu, B Karaca, et al.
Journal of Endocrinological Investigation|July 22, 2017
AT-101 acts as anti-proliferative and hormone suppressive agent in mouse pituitary corticotroph tumor cellsB S Yurekli, B Karaca, A Kisim, et al.
Experimental Oncology|December 17, 2009
The effect of racemic gossypol and at-101 on angiogenic profile of ovcar-3 cells: a preliminary molecular framework for gossypol enantiomersU Varol, B Karaca, D Tunali, et al.
Cell Biology International|September 1, 2009
Targeting apoptosis in the hormone- and drug-resistant prostate cancer cell line, DU-145, by gossypol/zoledronic acid combinationU A Sanli, G Gorumlu, C Erten, et al.
Medical Oncology (Northwood, London, England)|June 16, 2009
Efficacy and safety of bevacizumab plus capecitabine and irinotecan regimen for metastatic colorectal cancerM Degirmenci, B Karaca, G Gorumlu, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|November 4, 2008
Pegylated liposomal doxorubicin in heavily pretreated epithelial ovarian cancer patientsG Gorumlu, Y Kucukzeybek, M Kemal-Gul, et al.
Cancer|February 15, 1996
Involvement of the mitochondrion respiratory chain in the synergy achieved by treatment of human ovarian carcinoma cell lines with both tumor necrosis factor-alpha and cis-diamminedichloroplatinumR Uslu, B Bonavida
International Journal of Oncology|May 11, 2011
Free-radicals dependent and independent pathways of cddp-mediated cytotoxicity and apoptosis in ovarian tumor-cell linesR Uslu, B Bonavida
Cell Biology International|December 24, 2008
Docetaxel/zoledronic acid combination triggers apoptosis synergistically through downregulating antiapoptotic Bcl-2 protein level in hormone-refractory prostate cancer cellsB Karabulut, C Erten, M K Gul, et al.
Pageof 7